Sanofi on Thursday became the last major insulin maker to cut the price of the life-saving drug. Here’s why it’s been so expensive and what’s next.
Sanofi on Thursday became the last major insulin maker to cut the price of the life-saving drug. Here’s why it’s been so expensive and what’s next.
This website uses cookies. By continuing to use this site, you accept our use of cookies.